查找临床试验

已按「胰腺癌」检索,对应国际通用词 pancreatic cancer

试验不在中国怎么办?

共找到 275 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募I 期中国有中心NCT06821048

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

China

年龄 18 Years – 不限

Weijia Fang, MD

正在招募不适用中国有中心NCT03785743

Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma

China

年龄 18 Years – 75 Years

Tongji Hospital

正在招募II 期中国有中心NCT06405490

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

China

年龄 18 Years – 不限

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

正在招募不适用中国有中心NCT07557225

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

China

年龄 18 Years – 不限

Peking University First Hospital

正在招募IV 期中国有中心NCT06368063

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

China

年龄 18 Years – 80 Years

Xi'an Jiaotong University

正在招募II 期中国有中心NCT07784374

A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation

China

年龄 18 Years – 80 Years

Genfleet Therapeutics (Shanghai) Inc.

正在招募I 期 / II 期中国有中心NCT07692750

IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer

China

年龄 18 Years – 不限

Zhejiang Cancer Hospital

正在招募不适用中国有中心NCT05424159

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

China

年龄 18 Years – 80 Years

Shanghai Proton and Heavy Ion Center

正在招募II 期中国有中心NCT07769502

A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers

United States、Israel、Japan、Taiwan

年龄 18 Years – 不限

AbbVie

正在招募I 期 / II 期NCT06330064

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

United States、Argentina、Australia、Belgium、Brazil 等 12 国

年龄 18 Years – 不限

Daiichi Sankyo

正在招募I 期中国有中心NCT06898385

A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation

China

年龄 18 Years – 75 Years

Sun Yat-sen University

正在招募I 期中国有中心NCT06131840

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

United States、Canada、China、France、Israel 等 10 国

年龄 18 Years – 不限

Seagen, a wholly owned subsidiary of Pfizer